Parsa Kiai Purchases 43,150 Shares of Medifast (NYSE:MED) Stock

Medifast Inc (NYSE:MED) Director Parsa Kiai purchased 43,150 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The stock was bought at an average cost of $12.26 per share, for a total transaction of $529,019.00. Following the acquisition, the director owned 707,492 shares in the company, valued at approximately $8,673,851.92. The trade was a 6.50% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Parsa Kiai also recently made the following trade(s):

• On Monday, August 24th, Parsa Kiai acquired 4,329 shares of Medifast stock. The shares were bought at an average price of $12.00 per share, with a total value of $51,948.00.
• On Thursday, August 20th, Parsa Kiai bought 43,150 shares of Medifast stock. The stock was bought at an average cost of $11.60 per share, for a total transaction of $500,540.00.
• On Wednesday, August 19th, Parsa Kiai bought 29,337 shares of Medifast stock. The stock was bought at an average cost of $11.66 per share, for a total transaction of $342,069.42.

Medifast Stock Performance

Shares of MED opened at $12.17 on Friday. Medifast Inc has a 1 year low of $9.22 and a 1 year high of $14.67. The company has a market cap of $136.06 million, a price-to-earnings ratio of -5.22 and a beta of 0.65. The firm has a fifty day moving average of $11.00 and a 200-day moving average of $11.10.

Medifast (NYSE:MED) last posted its earnings results on Monday, August 3rd. The specialty retailer reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.65) by $0.37. Medifast had a negative net margin of 8.08% and a negative return on equity of 6.69%. The firm had revenue of $76.38 million during the quarter, compared to analysts’ expectations of $72.70 million. Medifast has set its FY 2026 guidance at -1.750–0.250 EPS and its Q3 2026 guidance at -0.650–0.150 EPS. Analysts predict that Medifast Inc will post -1.04 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. BNP Paribas Financial Markets raised its position in Medifast by 103.1% in the third quarter. BNP Paribas Financial Markets now owns 2,338 shares of the specialty retailer’s stock worth $32,000 after acquiring an additional 1,187 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Medifast during the 3rd quarter valued at about $37,000. Intesa Sanpaolo Wealth Management bought a new position in shares of Medifast during the 4th quarter valued at about $47,000. State of Wyoming acquired a new position in shares of Medifast in the 4th quarter worth approximately $59,000. Finally, Ancora Advisors LLC acquired a new position in shares of Medifast in the 2nd quarter worth approximately $75,000. 95.51% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on MED shares. Weiss Ratings upgraded shares of Medifast from a “sell (e+)” rating to a “sell (d)” rating in a research note on Monday, August 17th. Zacks Research lowered shares of Medifast from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $12.00.

About Medifast

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.